Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"recurrence free survival (RFS)"”.

  1. Deep Learning and Radiomics Based Outcome Prediction for Cancer Patients

    … and neck cancer (HNC) patients for locoregional recurrence (LRR) before radiotherapy using clinical data and PET/CT imaging. In addition, we developed a DL segmentation model to guide the extraction of radiomics features for HNC recurrence-free survival (RFS) prediction using data collected …

    utswmed Repository record for Deep Learning and Radiomics Based Outcome Prediction for Cancer Patients (opens in a new tab)

  2. Treatment outcomes of Her-2 positive Breast Cancer in the absence of Her-2 targeting agents at Groote Schuur Hospital, Cape Town, South Africa. Are we doing enough?

    … treatment significantly improves disease-free survival and overall survival of women with early-stage Her-2 positive breast cancer. However, at Groote Schuur Hospital anti-Her-2 targeted treatment is not available. We have therefore evaluated to what extent our patients may be …

    cape-town Repository record for Treatment outcomes of Her-2 positive Breast Cancer in the absence of Her-2 targeting agents at Groote Schuur Hospital, Cape Town, South Africa. Are we doing enough? (opens in a new tab)

  3. Tumour infiltrating T cells in non-small cell lung cancer and their interactions with cancer-associated fibroblasts

    … of CD39 amongst CD4+ T cells relates to poor recurrence free survival (RFS), whereas a high density of CD39+CD103+CD8+ T cells within tumour nest areas relates to improved survival at 5 years. In the second results chapter, bulk RNASeq (Nanostring nCounter) was used to assess the phenotype of …

    edinburgh Repository record for Tumour infiltrating T cells in non-small cell lung cancer and their interactions with cancer-associated fibroblasts (opens in a new tab)

  4. The perioperative setting as a platform for breast cancer biomarker development

    … therapy, is an accepted surrogate marker for survival outcomes in clinical trials (2). An advantage of the neoadjuvant setting is that tumour response to treatment can be assessed through tissue-based, biochemical, or radiologic changes throughout administration of therapy; allowing valuable …

    cork Repository record for The perioperative setting as a platform for breast cancer biomarker development (opens in a new tab)

  5. Development and validation of risk prediction model for colorectal cancer in patients with gastrointestinal symptoms

    … and 0.9 million CRC deaths. The overall 5-year survival rate of CRC is approximately 60%, showing an increasing trend by year. Early CRC diagnosis and timely treatment could largely prevent cancer deterioration. Early diagnosis could be enhanced through risk prediction models. Prediction model …

    edinburgh Repository record for Development and validation of risk prediction model for colorectal cancer in patients with gastrointestinal symptoms (opens in a new tab)